The Pharmaceutical Research and Manufacturers of America (PhRMA) has just adopted important revisions to its PhRMA Code on Interactions with Healthcare Professionals. The newly revised PhRMA Code, which builds on the previous 2002 version, and its likely impact on drug marketing, will be examined during this audio conference.
WilmerHale partner Scott Lassman will be a featured speaker for this audioconference.
We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.
